Moreover, B cell-derived CD39+ CD73+ EVs are elevated in the serum of colon cancer patients and hydrolyze tumor-derived ATP to ado, impairing anti-tumor responses of CD8+ T cells (84). Here, CD8A is linked to neoplasm.